An audit of immunisation status of sickle cell patients in Coventry, UK

Journal of Clinical Pathology

Volumn 62, Issue 1, 2009, Pages 42-45

  Howard Jones, M ^a   Randall, L ^b   Bailey Squire, B ^b   Clayton, J ^a   Jackson, N ^a  

^a UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

^b Department of Child Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MEDICAL AUDIT; NEISSERIA MENINGITIDIS; NEWBORN SCREENING; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; ENGLAND; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; MEDICAL AUDIT; MENINGOCOCCAL VACCINES; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PATIENT COMPLIANCE; PNEUMOCOCCAL VACCINES; PRACTICE GUIDELINES AS TOPIC; YOUNG ADULT;

EID: 58349092880     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.058982     Document Type: Article

References (27)

1. Barrett-Connor E. Bacterial infection and sickle cell anemia. Medicine 1971;50:97-112.
2. Pearson HA. Sickle cell anemia and severe infections due to encapsulated bacteria. J Infect Dis 1977;136:S25-30.
3. Landesman SH, Rao SP, Ahonklai VI. Infections in children with sickle cell anemia. Special reference to pneumococcal and salmonella infections. Am J Pediatr Hematol Oncol 1982:4;403-8.
4. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 1986;109:579-85.
5. Overturf GD. Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis 1999;14:191-218.
6. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007;44:1428-33.
7. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-27.
8. Kizito ME, Mworozi E, Ndugwa, et al. Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Arch Dis Child 2007;92:21-23.
9. Lucas SB, Mason DG, Mason M, et al. A sickle crisis? A report of the National Confidential Enquiry into Patient Outcome and Death (2008). NCEPOD, London, 2008.
10. John AB, Ramlal A, Jackson H, et al. Prevention of pneumococcal infection in children with homozygous sickle cell disease. Br Med J 1984;288:1567-70.
11. Gaston MH, Verier JL, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomised trial. N Engl J Med 1986;314:1593-9.
12. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 2008;121:562-9.
13. Davies EG, Hirst C, Lottenberg R, et al. Pneumococcal vaccines for sickle cell disease (review). Cochrane Database Syst Rev 2004; (1): CD003885.
14. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007;44:1428-33.
15. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103:4023-27.
16. Overturf GD, for the Committee on Infectious Diseases, American Academy of Pediatrics. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000;106:367-76.
17. Vernacchio L, Neufeld EJ, Mac Donald K, et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 1998;133:275-8.
18. Reinert P, Benkerrou M, de Montalembert M, et al. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease. Pediatr Infect Dis J 2007;26:1105-9.
19. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 2003;143:438-44.
20. World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Pec 2006:81:445-52.
21. Salisbury D, Ramsay M, Noakes K, eds. Immunisation against infectious disease ("The green book"). London: Department of Health, 2006.
22. Balmer P, Falconer M, McDonald P, et al. Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals. Infect Immun 2004;72:332-7.
23. Goldbiatt D, Johnson M, Evans J. Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease. Arch Dis Child 1996;75:159-61.
24. Atkinson W, Hamborsky J, Mclntyre L, Wolfe S, eds. Epidemiology and prevention of vaccine-preventable diseases ("The pink book"). 10th edn, 2nd printing. Washington (DC): Centers for Disease Control and Prevention, 2008.
25. Pebody RG, Hippisley-Cox J, Harcourt S, et al. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect 2008;136:360-9.
26. Department of Health. The influenza immunisation programme 2008/09. PL CMO (2008)3. 2008. http://www.dh.gov.uk (Search for: 9570).
27. Patel S; Howard J; Anie K. The use of a text messaging service to improve attendance at a sickle cell clinic. Br J Haematol 2007;137(Suppl 1):31.